Oral relugolix (40 mg GnRH antagonist + 1 mg estradiol + 0.5 mg norethindrone acetate) made available for 24 weeks was more effective than a placebo in relieving endometriosis pain at the initiation of therapeutic measures [106]. Here, GNRH1 is linked to endometriosis.